Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11097010 | 0.83 | KMT2A (0.36) | KMT2A | |
| SCHEMBL11099671 | 0.81 | TAAR1 (0.33) | CRBNKMT2A | |
| SCHEMBL11097616 | 0.81 | KMT2A (0.31) | CRBNKMT2A | |
| SCHEMBL12293892 | 0.80 | — | — | |
| SCHEMBL11190250 | 0.79 | KMT2A (0.42) | KMT2A | |
| SCHEMBL11100470 | 0.78 | ALDH1A1 (0.33) | — | |
| SCHEMBL11096238 | 0.77 | KMT2A (0.35) | KMT2A | |
| SCHEMBL11099386 | 0.77 | KMT2A (0.31) | KMT2A | |
| SCHEMBL28883614 | 0.74 | CYP3A4 (0.38) | KMT2AGRIA2LMNA | |
| SCHEMBL11098814 | 0.73 | GRM5 (0.32) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4477442-A | PENTOFURANOSYL-5,6-DIHYDROTRIAZINES IN TREATMENT OF VIRAL DISEASES | THE UPJOHN COMPANY (US) | 1984-10-16 | — | — | US | disclosed |
| US-4423212-A | Nucleosides and process | THE UPJOHN COMPANY (US) | 1983-12-27 | — | — | US | disclosed |
| US-4239753-A | Composition of matter and process | THE UPJOHN COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4171431-A | Nucleosides and process | THE UPJOHN COMPANY (US) | 1979-10-16 | — | — | US | disclosed |